<DOC>
	<DOCNO>NCT00161837</DOCNO>
	<brief_summary>The objective study assess immunogenicity safety inactivate influenza vaccine ( whole virion , Vero cell-derived ) Day 21 Day 180 vaccination .</brief_summary>
	<brief_title>Comparison Safety Immune Response Influenza Vaccine Made New Manufacturing Process With Vaccine Made Traditional Manufacturing Process Season 2003/2004</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female subject eligible participation study : &gt; = 18 &lt; = 60 year old ( Stratum A ) ; &gt; 60 year old ( Stratum B ) ; physical condition physician would reservations vaccinate influenza vaccine outside scope clinical trial ; reliably keep daily record symptom ; understand nature study , agree provision , give write informed consent ; female capable bearing child show negative pregnancy test result study entry agree employ adequate birth control measure duration study . Male female subject exclude participation study : receive influenza vaccine 2002/2003 season and/or 2003/2004 season ; suffer kind immunodeficiency ; suffer disease ( e.g . autoimmune disease ) undergo form treatment ( e.g . systemic corticosteroid , chemotherapeutics ) expect influence immunological function ; history inflammatory degenerative neurological disease ( e.g . Guillain Barr√© , multiple sclerosis ) ; receive blood transfusion immunoglobulin within one month study entry ; history vaccinerelated contraindicate event ( e.g . anaphylaxis ) ; rash dermatological condition may interfere injection site reaction rating ; know suspect problem drug alcohol abuse ; unable lead independent life either physically mentally ; administration investigational drug within six week prior study start ; concurrently participate clinical trial ; pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Vaccine</keyword>
</DOC>